RecallCheckr

Critical recall: Death or serious injury has been reported or is considered likely. Stop using this product now.

Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) 2023-06-28 Health critical FDA
Health · FDA · Recall #FDA-Z-1752-2023

CRT-D DTBC2QQ BRAVA QUAD IS4/DF4 INTL, Model Number DTBC2QQ; Implantable Cardioverter… Recall

Issued June 28, 2023 · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)

In June 2023, Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) recalled the CRT-D DTBC2QQ BRAVA QUAD IS4/DF4 INTL, Model Number DTBC2QQ; Implantable Cardioverter…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.

Compiled by Maya Ellison, RecallCheckr

What this means for you

There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.

What you should do

  1. 1 Stop using CRT-D DTBC2QQ BRAVA QUAD IS4/DF4 INTL, Model Number DTBC2QQ; Implantable Cardioverter… right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) to arrange your voluntary. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):

Recall details

Brand
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Category
Health
Recall date
June 28, 2023
Units affected
Not reported
Sold at
US Nationwide - Worldwide Distribution
Recall number
FDA-Z-1752-2023
Made in
United States
Issuing agency
FDA

In context

Read the official FDA notice

Related recalls